MINT-FENOFIBRATE E
MINT PHARMACEUTICALS INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is MINT-FENOFIBRATE E discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that MINT-FENOFIBRATE E 145MG has been permanently discontinued (last updated April 25, 2020). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is MINT-FENOFIBRATE E not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
LIPIDIL EZ
BGP PHARMA ULC
SPC-FENOFIBRATE E
SUN PHARMA CANADA INC
Other Products
LIPIDIL SUPRA
BGP PHARMA ULC
SANDOZ FENOFIBRATE E
SANDOZ CANADA INCORPORATED
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02465167
Strength
145MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
FENOFIBRATE
Tier
Unrated
Last Updated
2020-04-25
Reason for Shortage
Business reasons
Other Products from MINT PHARMACEUTICALS INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
300MG · DIN 02480956
10MG · DIN 02468840
25MG · DIN 02468859
200MG · DIN 02524708
400MG · DIN 02524716
800MG · DIN 02524724
70.0MG · DIN 02394871
5MG · DIN 02362651
10MG · DIN 02362678
1MG · DIN 02393573
5MG · DIN 02495449
2.5MG · DIN 02495430